Nonalcoholic steatohepatitis (NASH) develops when fat in the liver becomes toxic, killing liver cells and promoting inflammation and fibrosis. The disease can lead to cirrhosis, liver failure, and even death. It is associated with metabolic syndrome, which is characterized by abdominal obesity, high blood pressure, high blood sugar, low bloodRead
A recent review published in Nutrients examines the relationship between small intestinal bacterial overgrowth (SIBO) and non-alcoholic fatty liver disease (NAFLD). This relationship has gained research attention, as a growing body of evidence points to gut microbiota as playing a potentially causal role in NAFLD development and progression, including the promotion of the inflammatory response, hepaticRead
Are you missing the possibility of oxalates contributing to your patient’s fatigue, inflammation, pain, or chronic infections? In the absence of kidney stones, dietary oxalate has been overlooked as a cause of common aliments for nearly 100 years. Today’s health- and wellness-seeking patients often come to rely on oxalate-rich foodsRead
In a study published in Frontiers in Nutrition, Chinese scientists have reported a link between added sugars found in processed foods and an increased risk of kidney stones.
A study published in Nutrients shows that a diet comprising soy products, seafood, and other Japanese staples may benefit people with non-alcoholic fatty liver disease (NAFLD).
Omega-3 fatty acids from seafood and oily fish — not plants — are linked with a reduced risk of chronic kidney disease (CKD) and a slower decline in kidney function, according to a study published in The BMJ. Estimates show that CKD afflicts 700 million people in the world, causingRead
Patients with non-alcoholic fatty liver disease (NAFLD) have increased odds of depression, dementia, and other neurological conditions, according to a study in the Journal of Hepatology. NAFLD is usually caused by a high-sugar, high-fat diet, which has been linked to brain fog, mood imbalances, and other brain-related symptoms on itsRead
Covid is associated with increased liver stiffness, a sign of possible long-term liver injury, according to the results of a new study presented at this year’s annual meeting of the Radiological Society of North America (RSNA). Liver stiffness is a marker of liver damage, such as inflammation or fibrosis (theRead
A new study published in Chinese Medical Journal points to two new possible contributors to non-alcoholic fatty liver disease (NAFLD) — bile acids and lipid metabolism dysregulation. Typically associated with obesity, insulin resistance, and type 2 diabetes, NAFLD is characterized as a metabolic disease. NAFLD can progress into Nonalcoholic steatohepatitisRead
Non-alcoholic fatty liver disease (NAFLD) — a buildup of fat cells in the liver — affects up to 25% of people worldwide and is the most common chronic form of liver disease. There are now more reasons than ever to protect your liver: patients with fatty liver disease may face aRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
